In situ Fourier-transform infrared (FTIR) spectroscopy and scanning tunnelling microscopy (STM) have been used to investigate the nature of the 'activated' gold surface. The results suggest that the activation procedure leads to a situation where various relatively well defined surfaces can be formed on polycrystalline gold.
A series of three meso-tetra-alkyl porphyrins (H 2 TAPs) were synthesised and their electrochemical properties were studied in dichloromethane containing either tetra-butyl ammonium perclorate (TBAP) or tetra-butyl ammonium hexafluorophosphate TBA(PF 6 ) as supporting electrolyte (SE) by cyclic voltammetry and in situ UV/vis spectroelectrochemistry. Values of E 1/2 for the recorded four redox processes of these porphyrins and of the meso-tetra-phenyl porphyrin (H 2 TPP) on glassy carbon and platinum were measured and compared. The redox data collected on the first oxidation and the first reduction processes predict that the value of (LUMO − HOMO) for the H 2 TAPs is lower than for meso-tetra-phenyl porphyrin and, therefore, that the first Q band of the electronic spectra of the H 2 TAPs is red shifted relatively to the same band in the spectrum of H 2 TPP; this shift was indeed found. The second oxidation process of the H 2 TAPs is influenced by the supporting electrolyte used and the dication then formed is consumed by an irreversible chemical reaction. The species produced in this reaction is irreversibly reduced at a considerably lower potential. The electrochemical and spectroelectrochemical data collected are consistent with the occurrence of structural distortion in the macrocycle rings of the H 2 TAPs.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.